Meral Topçu1, Dilek Aktas2,3, Merih Öztoprak4, Neslihan Önenli Mungan5, Aysel Yuce6, Mehmet Alikasifoglu2,3. 1. Division of Pediatric Neurology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Sıhhıye, 06100, Ankara, Turkey. mtopcu@hacettepe.edu.tr. 2. Department of Medical Genetics, Hacettepe University Faculty of Medicine, Ankara, Turkey. 3. DAMAGEN Genetic Diagnostic Center, Ankara, Turkey. 4. Division of Pediatric Neurology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Sıhhıye, 06100, Ankara, Turkey. 5. Department of Pediatric Metabolism and Nutrition, Çukurova University Faculty of Medicine, Adana, Turkey. 6. Division of Pediatric Gastroenterology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Abstract
BACKGROUND: Niemann-Pick disease Type C (NP-C) is a rare, autosomal recessive lysosomal storage disorder caused by mutations in NPC1 or NPC2 genes. Diagnosis of NP-C can be challenging and is frequently delayed. Identifying mutations in individuals with NP-C and their relatives enables genetic counseling and prenatal diagnosis and may support earlier diagnosis. Here we report findings from a prospective cohort study in Turkey, using targeted genetic screening of the families of NP-C probands with homozygous NPC1 or NPC2 mutations. METHODS: Probands were selected from a Turkish National Registration Database. Probands had confirmed diagnosis based on NPC1 or NPC2 mutations, with clear indication for consanguineous, homozygous inheritance. Family members were identified from interviews and pedigree analysis. Genetic analysis was performed on DNA from peripheral blood samples from all subjects. RESULTS: Four probands and 510 individuals from the four families were included. In these four families, the overall NPC1 or NPC2 heterozygous mutation frequency was 22.7%. A novel mutation was identified in NPC1 (p.T375P; c.1123A>C). A previously described NPC2 mutation (p.E118X; c.352G>T) was also observed in two families from different regions of Turkey. We identified two new patients with NP-C from two families. CONCLUSIONS: This is the largest screening study conducted to date in Turkey in the families of patients with NP-C with homozygous inheritance. We have reported heterozygote frequencies, identified a novel mutation, and detected new patients with NP-C. These findings will aid our understanding of NP-C and may lead to improved recognition and more timely diagnosis.
BACKGROUND:Niemann-Pick disease Type C (NP-C) is a rare, autosomal recessive lysosomal storage disorder caused by mutations in NPC1 or NPC2 genes. Diagnosis of NP-C can be challenging and is frequently delayed. Identifying mutations in individuals with NP-C and their relatives enables genetic counseling and prenatal diagnosis and may support earlier diagnosis. Here we report findings from a prospective cohort study in Turkey, using targeted genetic screening of the families of NP-C probands with homozygous NPC1 or NPC2 mutations. METHODS: Probands were selected from a Turkish National Registration Database. Probands had confirmed diagnosis based on NPC1 or NPC2 mutations, with clear indication for consanguineous, homozygous inheritance. Family members were identified from interviews and pedigree analysis. Genetic analysis was performed on DNA from peripheral blood samples from all subjects. RESULTS: Four probands and 510 individuals from the four families were included. In these four families, the overall NPC1 or NPC2 heterozygous mutation frequency was 22.7%. A novel mutation was identified in NPC1 (p.T375P; c.1123A>C). A previously described NPC2 mutation (p.E118X; c.352G>T) was also observed in two families from different regions of Turkey. We identified two new patients with NP-C from two families. CONCLUSIONS: This is the largest screening study conducted to date in Turkey in the families of patients with NP-C with homozygous inheritance. We have reported heterozygote frequencies, identified a novel mutation, and detected new patients with NP-C. These findings will aid our understanding of NP-C and may lead to improved recognition and more timely diagnosis.
Authors: H Watari; E J Blanchette-Mackie; N K Dwyer; M Watari; E B Neufeld; S Patel; P G Pentchev; J F Strauss Journal: J Biol Chem Date: 1999-07-30 Impact factor: 5.157
Authors: F A Wijburg; F Sedel; M Pineda; C J Hendriksz; M Fahey; M Walterfang; M C Patterson; J E Wraith; S A Kolb Journal: Neurology Date: 2012-04-18 Impact factor: 9.910
Authors: I Mavridou; M Cozar; S Douzgou; A Xaidara; D Lianou; M T Vanier; E Dimitriou; D Grinberg; L Vilageliu; H Michelakakis Journal: Clin Genet Date: 2013-06-12 Impact factor: 4.438
Authors: Christopher A Wassif; Joanna L Cross; James Iben; Luis Sanchez-Pulido; Antony Cougnoux; Frances M Platt; Daniel S Ory; Chris P Ponting; Joan E Bailey-Wilson; Leslie G Biesecker; Forbes D Porter Journal: Genet Med Date: 2015-03-12 Impact factor: 8.822
Authors: María-Jesús Sobrido; Peter Bauer; Tom de Koning; Thomas Klopstock; Yann Nadjar; Marc C Patterson; Matthis Synofzik; Chris J Hendriksz Journal: Orphanet J Rare Dis Date: 2019-01-21 Impact factor: 4.123